Jason G. Newland, MD, MEd

Washington University in St. Louis School of Medicine

Disclosure(s): Moderna: Grant/Research Support; Pfizer: Grant/Research Support

Poster(s):

• (P-700) Examining the Knowledge, Availability, Access and Uptake of RSV Immunoprophylasis among RSV Hospitalized Infants
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-1118) Clinician knowledge, attitudes, and practices around empiric vancomycin use in the pediatric intensive care unit
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1140) Antimicrobial Stewardship Curriculum Development for Pediatric Residents
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1141) Antibiotic administration for Staphylococcus aureus infections in US children's hospitals, 2015-2023
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1201) Impact of Demographic Factors and Social Determinants of Health on RSV Immunoprophylaxis in Infants
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1748) Reducing Inappropriate Post-Operative Antibiotics in Pediatrics: The Optimizing PERioperative AnTibiotics In Children (OPERATIC) Trial
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT

• (P-1774) Order sets paired with facilitation training to effectively reduce postoperative surgical prophylaxis
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT

• (P-1804) Evaluating Implementation Outcomes of Stewardship Interventions for Rapid Blood Culture Diagnostics
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT